Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review.

European journal of clinical pharmacology - 1 Jul 2023

Wang Cheng-Bin, Zhang Yu-Jia, Zhao Ming-Ming, Zhao Li-Mei

Abstract excerpt

BACKGROUND AND OBJECTIVES: Tacrolimus (TAC) has been increasingly used in patients with non-transplant settings. Because of its large between-subject variability, several population pharmacokinetic (PPK) studies have been performed to facilitate individualized therapy. This review summarized published PPK models of TAC in non-transplant patients, aiming to clarify factors affecting PKs of TAC and identify the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Cytochrome P-450 CYP3A
Share to Ethnicity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Immunosuppressive Agents

Share to Models, Biological

Share to Tacrolimus

Source

Identifiers

PMID: 37261481
DOI: 10.1007/s00228-023-03503-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population pharmacokinetic analyses of tacrolimus in non-transplant patients: a systematic review.PMID 37261481Read ↗

Population Pharmacokinetic Models for Tacrolimus in non-transplant patients: A Systematic ReviewSemantic proximity Read ↗

Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: A systematic review.Semantic proximity Read ↗

Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review.Semantic proximity Read ↗

Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.Semantic proximity Read ↗

Population pharmacokinetics of tacrolimus in Chinese adult liver transplant patients.Semantic proximity Read ↗

Impact of Donor and Recipient CYP3A5*3 Genotype on Tacrolimus Population Pharmacokinetics in Chinese Adult Liver Transplant Recipients.Semantic proximity Read ↗

Population pharmacokinetics of tacrolimus and CYP3A5-driven variability: implications for model-informed dose individualization in pediatric renal transplant recipients.Semantic proximity Read ↗

A population pharmacokinetic model for early follow-up dosing of tacrolimus in Tunisian kidney transplant recipients.Semantic proximity Read ↗

Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.Semantic proximity Read ↗

Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.Semantic proximity Read ↗

Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients.Semantic proximity Read ↗

Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.